ITGAM and neoplasm: It was reported that using CD11b neutralizing antibodies can sensitize the therapeutic effect of radiation by reducing infiltration of myeloid cells [35]; however, using a CD11b-activating molecule was shown to suppress tumor growth via pro-inflammatory macrophages, likely M1-polarized macrophages [36].